Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $11,697,909 | $6,215,101 | $3,817,198 | $2,686,650 |
| - Cash | $185,823 | $248,329 | $206,953 | $53,048 |
| + Debt | $16,688 | $5,328 | $7,503 | $2,685 |
| Enterprise Value | $11,528,774 | $5,972,100 | $3,617,748 | $2,636,287 |
| Revenue | $654 | $10,637 | $36,964 | $0 |
| % Growth | -93.9% | -71.2% | – | – |
| Gross Profit | -$1,047 | $9,525 | $36,458 | -$145 |
| % Margin | -160.1% | 89.5% | 98.6% | – |
| EBITDA | -$493,076 | -$259,628 | -$143,151 | -$68,511 |
| % Margin | -75,393.9% | -2,440.8% | -387.3% | – |
| Net Income | -$433,680 | -$276,336 | -$143,805 | -$68,554 |
| % Margin | -66,311.9% | -2,597.9% | -389% | – |
| EPS Diluted | -11.73 | -8.74 | -4.94 | -2.59 |
| % Growth | -34.2% | -76.9% | -90.7% | – |
| Operating Cash Flow | -$385,819 | -$228,006 | -$100,878 | -$69,856 |
| Capital Expenditures | -$2,917 | -$915 | -$3,072 | -$419 |
| Free Cash Flow | -$388,736 | -$228,921 | -$103,950 | -$70,275 |